INNATRIX, INC.

Agritech · Still private

Peptide-based bioactive compounds designed to bind pathogen proteins and prevent crop disease infection

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Agritech
Total capital
$1.6M
Federal grants
$1.6M
3 awards · 2020–2025
Rank in peer group#12 of 27
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
2 pending

Capital timeline

202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $1.6M$250K$1.2M$175K
202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $1.6M$250K$1.2M$175K

Latest events

  • Federal grantAgriculture · Soybean Cyst Nematode (scn) Is The Most Damaging Pest To Soybean Crops In The U.S., Causing Over $1.5 Billion In Annual Losses. Current Methods, Like Resistant Soybean Varieties And Crop Rotation, Are Becoming Less Effective, And Chemical Treatments Can Be Costly Or Environmentally Harmful. Innatrix Is Developing A New, Eco-friendly Way To Protect Soybean Plants Using Rna Interference (rnai). By Applying Double-stranded Rna (dsrna) To Seeds, We Aim To Turn Off Specific Nematode Genes That Are Es$175K
  • Federal grantNSF · Phase II · SBIR Phase II: Development of eco-friendly peptide bioprotectant for devastating late blight control$1.2M
  • Federal grantNSF · Phase I · SBIR Phase I: Directed protein evolution: Creating high affinity protein ligands for controlling economically detrimental plant pathogens and pests$250K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 27 peers

Line = median

Agritech · Molecule

  • Federal grants#12 · top 44%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 2
  • PendingBioprotectant Peptides For The Prevention Of Late BlightUSPTOApplication 19141272
  • PendingBioprotectant Peptides For The Prevention Of Late BlightUSPTOApplication PCTUS2023085246
  • ArkeaBioSimilar federal contract value in Agritech · null in contracts
  • Verinomics, Inc.Similar federal contract value in Agritech · null in contracts
  • AXATSimilar federal contract value in Agritech · null in contracts
  • HJ SCIENCE & TECHNOLOGY INCSimilar federal contract value in Agritech · null in contracts
  • Terrana BiosciencesSimilar federal contract value in Agritech · null in contracts
  • TUBS, INC.Similar federal contract value in Agritech · null in contracts

Regulatory activity · Agritech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .